Close Menu

NEW YORK (360DX) – Biomarker-based diagnostics firm Kypha announced it has acquired diagnostics platform and contract development company Biosensia.

Biosensisa will operate as a wholly owned subsidiary of Kypha. Further financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.